Market Currents
NPS Pharmaceuticals (NPSP) +8.3% premarket after the company and drug partner Takeda (TKPHF.PK)...
-
Friday, June 22, 2012, 9:03 AM ETNPS Pharmaceuticals (NPSP) +8.3% premarket after the company and drug partner Takeda (TKPHF.PK) say a European panel recommended their Revestive drug receive marketing approval as a once-daily treatment for adults with short bowel syndrome.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
